1. Home
  2. REVB vs YHC Comparison

REVB vs YHC Comparison

Compare REVB & YHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

N/A

Current Price

$3.74

Market Cap

1.9M

Sector

Health Care

ML Signal

N/A

Logo LQR House Inc.

YHC

LQR House Inc.

N/A

Current Price

$1.61

Market Cap

2.2M

ML Signal

N/A

Company Overview

Basic Information
Metric
REVB
YHC
Founded
2020
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.9M
2.2M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
REVB
YHC
Price
$3.74
$1.61
Analyst Decision
Analyst Count
0
0
Target Price
★ $124.25
N/A
AVG Volume (30 Days)
64.7K
★ 235.0K
Earning Date
11-05-2026
11-17-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 72.68
N/A
EPS
N/A
★ 8.28
Revenue
N/A
★ $1,120,622.00
Revenue This Year
N/A
$1,254.00
Revenue Next Year
N/A
$21.74
P/E Ratio
★ N/A
$0.27
Revenue Growth
N/A
★ 86.42
52 Week Low
$0.44
$1.21
52 Week High
$4.75
$4,480.00

Technical Indicators

Market Signals
Indicator
REVB
YHC
Relative Strength Index (RSI) 65.12 42.90
Support Level $0.97 $1.41
Resistance Level $4.06 $1.97
Average True Range (ATR) 0.36 0.44
MACD 0.01 -0.02
Stochastic Oscillator 27.56 20.24

Price Performance

Historical Comparison
REVB
YHC

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

Share on Social Networks: